Arizona-based researcher Dr. Sue Sisley is spearheading an extraordinary lawsuit against the U.S. Drug Enforcement Administration (DEA), demanding that the agency stop dragging its feet on a years-old promise to end the federal government’s monopoly on growing cannabis for clinical research.
“The findings demonstrate the potential for this new cannabis derivative in the treatment of both localized and advanced pancreatic cancer,” the study’s authors wrote. “The results justify further studies to optimize therapy outcomes toward clinical translation.”
Researchers at the University of California, Davis, have partnered with a federally compliant pharmaceutical company to analyze the chemical and biological profiles of cannabis for the benefit of law enforcement, health care providers and scientific professionals.
CBDV, or cannabidivarin, is one of many molecules derived from cannabis and hemp plants.
CBN –an abbreviation of Cannabinol– comes from the oxidation and decomposition of THC from a hemp plant, meaning that when THC is heated and exposed to Co2 (oxygen), it converts to CBN.
Imagine a pain reliever 30 times stronger at reducing inflammation than Aspirin. Researchers at the University of Guelph in Canada are the first to uncover the pain-relief potential of cannabis, demonstrating just how strong the plant could be.
Terpenes, terpenoids, terps. Whatever you call them, these compounds in cannabis that give it distinctive aromas and flavors are popping up in consumer products everywhere.
Being wind pollinated, hemp plants produce large amounts of pollen that are attractive to bees.
The discovery of cannabis pollen near a Viking settlement in Newfoundland raises the question of whether the Vikings were smoking or eating pot while exploring North America.
The U.S. government is growing the largest crop of research marijuana in five years, responding to interest in varieties with high levels of THC and CBD.
Cannabis may have originated high on the Tibetan Plateau, according to an analysis of fossil pollen.
“Although we have much still to learn, it appears that in some situations, the ECS acts as a volume control for a variety of processes and factors, modulating the way our body interprets signals, whether they be pain, hunger, excitement, etc.”
A new wave of research points toward cannabinoids having an adaptive, immunomodulating effect, rather than just suppressing immune activity.
In what is believed to be the largest private gift yet to support scientific research on cannabis, a donor is giving $9 million to support Harvard and MIT work on cannabis and its effects on the brain.
Verda Bio won the state's first pot research license last November, giving the company special privileges to study cannabis and create new technology.
Researchers are currently seeking volunteers willing to smoke up and get behind the wheel of a sophisticated driving simulator. The only catch: You’ve got to bring your own cannabis.